Jul 14 2009
Integrated Sensing Systems, Inc. (ISSYS) announced that it has signed an intellectual property licensing agreement with Affinity Biosensors, LCC of Santa Barbara, CA. Affinity Biosensors is developing and commercializing methods of measuring and monitoring particles, cells, bacteria, and viruses using resonating micromachined tubes. Specialists in MEMS technology, ISSYS has developed resonating silicon microtubes for more than a decade for a variety of applications. The licensing agreement allows Affinity Biosensors to use ISSYS' microtube fabrication technology to develop more advanced versions of their unique particulate sensors.
Dr. Nader Najafi, ISSYS President and CEO, stated, "This agreement allows Affinity Biosensors to take ISSYS' basic technology into new directions and helps Affinity Biosensors tap new markets in particle detection. ISSYS has used this same technology to develop and launch a variety of microfluidic products like density, chemical concentration and Coriolis mass flow sensors. These sensors have been applied in medical, fuel cell, industrial and fuel handling applications. We are excited to see the technology being applied to biological detection markets."
Dr. Ken Babcock, Affinity Biosensors' CEO, added, "We are pleased to be able to use ISSYS' MEMS processing technology to improve our particle sensors. We anticipate improvements in yield and cost that will translate to better value for our customers having demanding applications in nanoparticle and biological measurements."